K050338

Substantially Equivalent

MODIFICATION TO: INSTAREAD LITHIUM SYSTEM

Applicant: Akers Biosciences, Inc.
Product code: JIH
Advisory panel: Clinical Toxicology
Date received: 2005-02-11
Decision date: 2005-03-04
Decision: Substantially Equivalent
Clearance type: Special
Location: Thorofare, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.